Neuro-Oncology: The Podcast

88 Episodes

1. BOLD fMRI in IDH mutant gliomas

   Published: 10/12/2021
2. Glioblastoma subtypes and response to Dasatinib

   Published: 26/11/2021
3. Resection for recurrent brain metastases

   Published: 12/11/2021
4. Incidental Meningiomas

   Published: 29/10/2021
5. Immunosuppression in IDH mutant gliomas

   Published: 15/10/2021
6. Immunotherapy for melanoma brain metastases

   Published: 01/10/2021
7. DNA methylation profiles within the CATNON trial

   Published: 17/09/2021
8. 18F FET PET in childhood CNS tumors

   Published: 03/09/2021
9. Checkpoint blockade in atypical meningiomas

   Published: 20/08/2021
10. Molecular signatures of glioma causation

    Published: 06/08/2021
11. Testing methods for MGMT promoter methylation

    Published: 23/07/2021
12. Temozolomide-induced hypermutation in IDH-mutant low-grade gliomas

    Published: 09/07/2021
13. Posterior fossa syndrome

    Published: 18/06/2021
14. Loss of H3K27me3 in meningiomas

    Published: 04/06/2021
15. Loss of H3K27me3 in the Tübingen meningioma cohort

    Published: 21/05/2021
16. A prospective phase II randomized trial of proton radiotherapy vs intensity modulated radiotherapy for patients with newly diagnosed GBM

    Published: 07/05/2021
17. Brain radiotherapy and decline in fine motor skills

    Published: 09/04/2021
18. A serum based DNA methylation assay to detect gliomas

    Published: 26/03/2021
19. PTEN deficiency and proteosome addiction in glioblastoma

    Published: 12/03/2021
20. Cold-Inducible RNA-Binding Protein expression and recurrence of brain metastases

    Published: 26/02/2021